BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4
22 results:

  • 1. Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process.
    Honar YS; Javaher S; Soleimani M; Zarebkohan A; Farhadihosseinabadi B; Tohidfar M; Abdollahpour-Alitappeh M
    Sci Rep; 2023 Oct; 13(1):17265. PubMed ID: 37828118
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models.
    Schwarcz S; Kovács P; Kovács T; Ujlaki G; Nyerges P; Uray K; Bai P; Mikó E
    Mol Biol Rep; 2023 Jun; 50(6):5273-5282. PubMed ID: 37145211
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
    Gan M; Tai Z; Yu Y; Zhang C; Xu J
    PeerJ; 2023; 11():e14653. PubMed ID: 36721777
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic performance of microRNAs in testicular germ cell tumors: a systematic review and meta-analysis.
    Zhao XY; Gao YL; Li DF; Liu HC; Zhu RF; Zhu CT
    Aging (Albany NY); 2021 Aug; 13(15):19657-19677. PubMed ID: 34343969
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt/β-catenin signaling.
    Gokturk F; Erkoc-Kaya D; Arikoglu H
    Bratisl Lek Listy; 2021; 122(2):132-137. PubMed ID: 33502882
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid cancer Invasion.
    Nicolson NG; Paulsson JO; Juhlin CC; Carling T; Korah R
    Endocr Pathol; 2020 Dec; 31(4):367-376. PubMed ID: 33063251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. WNT signalling in the normal human adult testis and in male germ cell neoplasms.
    Young JC; Kerr G; Micati D; Nielsen JE; Rajpert-De Meyts E; Abud HE; Loveland KL
    Hum Reprod; 2020 Sep; 35(9):1991-2003. PubMed ID: 32667987
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
    Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
    Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vitamin D Suppresses Ovarian cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2.
    Wang L; Zhou S; Guo B
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230936
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adiponectin Suppresses Human Pancreatic cancer Growth through Attenuating the β-Catenin Signaling Pathway.
    Jiang J; Fan Y; Zhang W; Shen Y; Liu T; Yao M; Gu J; Tu H; Gan Y
    Int J Biol Sci; 2019; 15(2):253-264. PubMed ID: 30745818
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Three-dimensional analysis reveals altered chromatin interaction by enhancer inhibitors harbors tcf7l2-regulated cancer gene signature.
    Gerrard DL; Wang Y; Gaddis M; Zhou Y; Wang J; Witt H; Lin S; Farnham PJ; Jin VX; Frietze SE
    J Cell Biochem; 2019 Mar; 120(3):3056-3070. PubMed ID: 30548288
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. tcf7l2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer.
    Xiang J; Hu Q; Qin Y; Ji S; Xu W; Liu W; Shi S; Liang C; Liu J; Meng Q; Liang D; Ni Q; Xu J; Zhang B; Yu X
    Cell Death Dis; 2018 Feb; 9(3):321. PubMed ID: 29476053
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian cancer Stem Cell Spheroids.
    Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
    Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
    [No Abstract]    [Full Text] [Related]  

  • 14. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gene Expression Signature in Adipose Tissue of Acromegaly Patients.
    Hochberg I; Tran QT; Barkan AL; Saltiel AR; Chandler WF; Bridges D
    PLoS One; 2015; 10(6):e0129359. PubMed ID: 26087292
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan.
    Kuruma S; Egawa N; Kurata M; Honda G; Kamisawa T; Ueda J; Ishii H; Ueno M; Nakao H; Mori M; Matsuo K; Hosono S; Ohkawa S; Wakai K; Nakamura K; Tamakoshi A; Nojima M; Takahashi M; Shimada K; Nishiyama T; Kikuchi S; Lin Y
    World J Gastroenterol; 2014 Dec; 20(46):17456-62. PubMed ID: 25516658
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SPINDLIN1 promotes cancer cell proliferation through activation of WNT/tcf-4 signaling.
    Wang JX; Zeng Q; Chen L; Du JC; Yan XL; Yuan HF; Zhai C; Zhou JN; Jia YL; Yue W; Pei XT
    Mol Cancer Res; 2012 Mar; 10(3):326-35. PubMed ID: 22258766
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
    PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Integrin regulation of beta-catenin signaling in ovarian carcinoma.
    Burkhalter RJ; Symowicz J; Hudson LG; Gottardi CJ; Stack MS
    J Biol Chem; 2011 Jul; 286(26):23467-75. PubMed ID: 21518759
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. No association between a candidate tcf7l2 variant and risk of breast or ovarian cancer.
    Goode EL; Szabo C; Prokunina-Olsson L; Vierkant RA; Fredericksen ZS; Collins FS; White KL; Schmidt M; Fridley BL; Couch FJ
    BMC Cancer; 2009 Sep; 9():312. PubMed ID: 19732438
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.